StockNews.com Initiates Coverage on Bio-Path (NASDAQ:BPTH)

Equities researchers at StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report issued on Thursday. The firm set a “sell” rating on the stock. Separately, Roth Capital reaffirmed a “buy” rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Performance Shares of NASDAQ:BPTH opened […]

Related Keywords

Douglasp Morris ,Peterh Nielsen ,Gabriel Lopez Berestein ,Path Company Profile ,Nasdaq ,Virtu Financial ,Citadel Advisors ,Renaissance Technologies ,Path Holdings Inc ,Get Rating ,Roth Capital ,Path Holdings ,Ana Tari Ashizawa ,Bio Path Daily ,Bio Path ,Nasdaq Bpth ,Bpth ,Medical ,Initiated Coverage ,Stocknews Com ,